Delivery Order SPE2DB22D3011-SPE2DB24FQ1VX
Award Date 6/10/24
Potential Completion Date 6/11/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,645.38 firm fixed price contract is for the supply of Micardis HCT 80-25 mg tablets in 30-count units. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.20 delivery order contract is for the supply of Micardis HCT 80-25 mg tablets, a cardiovascular medication. The contract is a firm fixed-price, delivery order type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,242.18, is for the supply of Micardis HCT 80-12.5 mg tablet medication. The contract is a firm-fixed price delivery order, with a period of performance through November 8, 2024. No set-aside designation was used for this award. In addition to this delivery order, AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,862.19, is for the delivery of Micardis HCT 40-12.5 mg tablets to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 3, 2023. The contract has no set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,022.14, is for the delivery of Micardis HCT 80-12.5 mg tablets. It is a firm fixed-price delivery order contract that runs through July 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,521.63 fixed-price contract is for the delivery of MICARDIS HCT 40-12.5 mg tablets through November 30, 2023. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
- This is a $4,993.21 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Micardis HCT 80-25 mg tablets, a cardiovascular medication, with a completion date of November 29, 2023. The award is not associated with a set-aside program. In addition to this delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) has awarded a $3,358.12 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,813,873 units of the drug Micardis HCT 80-25 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the government to efficiently procure a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,237.30, is for the delivery of Micardis HCT 40-12.5 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Micardis HCT 80-12.5 mg tablets, a cardiovascular medication, valued at $4,209.48. The contract has an ultimate completion date of October 22, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...